Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Trial of Roflumilast in Asthma Management (TRIM)

Trial Profile

Trial of Roflumilast in Asthma Management (TRIM)

Phase of Trial: Phase II

Latest Information Update: 14 Nov 2018

At a glance

  • Drugs Roflumilast (Primary)
  • Indications Asthma
  • Focus Therapeutic Use
  • Acronyms TRIM
  • Most Recent Events

    • 27 Aug 2018 Planned primary completion date changed from 1 Oct 2019 to 1 Apr 2020.
    • 16 Aug 2018 Status changed from not yet recruiting to recruiting.
    • 24 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top